Longitudinal analysis reveals breast cancer recurrence risk persists up to 32 years after initial diagnosis, suggesting a need for extended surveillance.
Recurrences continued to occur up to 32 years after primary diagnosis. Women with high lymph node burden, large tumor size, and estrogen receptor-positive tumors had increased risk of late recurrence. Such patients may warrant extended surveillance, more aggressive treatment, or new therapy approaches.
No takes yet. Share an insight, caveat, or question.
Pedersen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: